|
Chain Drug Review
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 108 articles |
 Page 1 of 2 
|
AMP fight far from over.
September 29, 2008
Rx paper rules to kick in.
September 29, 2008
Plan to cut costs.
September 29, 2008
Chains do part with specials.
September 29, 2008
ICPT touts certification program.
September 29, 2008
J&J, Red Cross to share trademark.
September 29, 2008
Cloth diapers get another look.
September 29, 2008
Pharmacy coverage in Canada faulted.
September 29, 2008
GPhA makes case for biogenerics.
September 29, 2008
FTC is considering Teva's acquisition of Barr.
September 29, 2008
Lower Part D costs anticipated in 2009.
September 29, 2008
Conference focuses on e-prescribing.
September 29, 2008
Priority review granted.
September 29, 2008
Generics discounts offered by Marc's.
September 29, 2008
Judge alters Medi-Cal ruling.
September 29, 2008
JPMA makes safety a top priority.
September 29, 2008
Rx ads' impact questioned.
September 29, 2008
Omnitrope Pen 10 to hit market.
September 29, 2008
Baby bottle safety stirs debate.
September 29, 2008
Big influx of personnel should benefit the FDA.
September 29, 2008
HIT legislation spurs debate.
September 29, 2008
DNA test for hepatitis B approved.
September 29, 2008
Pricing for profit denied.
September 29, 2008
Medicaid cuts hit S.C.
September 29, 2008
Humana faces loss of enrollees.
September 29, 2008
Court allows suit against drug firms.
September 29, 2008
Lawsuit against McKesson dismissed.
September 29, 2008
CE catalog highlights.
September 29, 2008
Ways to treat hypertension without drugs.
September 29, 2008
Investors blast Longs board.
September 29, 2008
Outlook for biosimilars is promising.
September 29, 2008
Wal-Mart reduces more prices.
September 29, 2008
Demographic trends constrain sales growth.
September 29, 2008
Digital imaging results in new opportunities.
September 29, 2008
Longs net rises 3.3% on strength of its PBM business.
September 29, 2008
Premier Brands unveils deodorants.
September 29, 2008
New generics win approval from the FDA.
September 29, 2008
Security wrap gets message across where it counts most.
September 29, 2008
GM looms large in chains' business plan.
September 29, 2008
DVDs find a home in product mix.
September 29, 2008
Economic woes cast shadow on drug chains.
September 29, 2008
Priority review.
September 29, 2008
FDA bans imports of Ranbaxy drugs.
September 29, 2008
Healthy food, beverages take center stage.
September 29, 2008
A new communication model.
September 29, 2008
Making every message count.
September 29, 2008
Expo to provide in-store insights.
September 29, 2008
Rx front-end link is reinforced.
September 29, 2008
Innovation automates Macey's Rx operations.
September 29, 2008
Marketing tools violate regulations.
September 29, 2008
Nexcare expansion.
September 29, 2008
Nature's Bounty is going green.
September 29, 2008
Discontinued operations take toll at Cardinal.
September 29, 2008
Profit forecast short of Wall Street's.
September 29, 2008
Suppliers' results are impressive.
September 29, 2008
Rx should brace for impact of financial crisis.
September 29, 2008
Vivitek unveils digital signs.
September 29, 2008
CVS promoting semiannual beauty sale.
September 29, 2008
Fred Meyer goes digital.
September 29, 2008
Cellzome, GSK sign R&D pact.
September 29, 2008
Drug makers try lifecycle management.
September 29, 2008
Perrigo acquires rights.
September 29, 2008
Razadyne to get generic rival.
September 29, 2008
First aid edges into spotlight.
September 29, 2008
Nature's Bounty is going green.
September 29, 2008
Discontinued operations take toll at Cardinal.
September 29, 2008
Profit forecast short of Wall Street's.
September 29, 2008
Suppliers' results are impressive.
September 29, 2008
Rx should brace for impact of financial crisis.
September 29, 2008
Vivitek unveils digital signs.
September 29, 2008
CVS promoting semiannual beauty sale.
September 29, 2008
Fred Meyer goes digital.
September 29, 2008
Cellzome, GSK sign R&D pact.
September 29, 2008
Drug makers try lifecycle management.
September 29, 2008
Perrigo acquires rights.
September 29, 2008
More
articles from Chain Drug Review...
|